LIPIKAR MILK UREA 10% 400 ML

LA ROCHE-POSAY Lipikar Urea 10% Triple-Action Moisturizing Body Lotion: NEW triple-action moisturizing treatment for very dry and rough skin. Helps to immediately reduce the signs of dry skin and their reappearance: roughness, flaking, tightness and itching sensations to restore smoother, soothed and comfortable skin. BENEFITS NEW FORMULA WITH CLINICALLY PROVEN EFFICACY: 10% Urea with a natural keratolytic effect to target all signs of dry skin, improve cell renewal and preserve skin hydration Allantoin to soothe feelings of irritation and deeply hydrate the skin by retaining water, while stimulating cell regeneration. Shea Butter to nourish, deeply hydrate and give the skin the ideal fatty acid content. PROVEN BENEFITS: Immediately REDUCES signs of dry skin and their reappearance: roughness, flaking, tightness and itching. RESTORES skin elasticity. SOOTHES AND SMOOTHES even extremely dry skin appears smoother. NEW FORMULA WITH CLINICALLY PROVEN EFFICACY: 10% Urea with a natural keratolytic effect to target all signs of dry skin, improve cell renewal and preserve skin hydration Allantoin to soothe feelings of irritation and deeply hydrate the skin by retaining water, while stimulating cell regeneration. Shea Butter to nourish, deeply hydrate and give the skin the ideal fatty acid content. 1/ IMMEDIATELY REDUCES SIGNS OF SKIN DRYNESS AND THEIR REPEAL Roughness, scales, feelings of tightness and itching 2/ RESTORES SKIN ELASTICITY 3/ SOOTHES AND SMOOTHES Even extremely dry skin appears smoother. BENEFITS -98% dryness from the first application (clinical study on 54 subjects after one application) 48-hour anti-irritation efficacy (clinical study on 49 subjects for 14 days and measurement two days after the last application). 86% more supple skin from the first application (clinical study on 54 subjects after 1 use) 92% smoother skin from the first application (clinical study on 42 subjects, 6 hours after application) INDICATION Very dry, rough, scaly skin. Children, Adults and Seniors. Clinically tested on skin prone to kerastosis pilaris, senile xerosis and psoriasis.